Position in VRTX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$40,495,910
+$3,263,407 QoQ
Shares Held
81,525
-2.2% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#191
of 1,742 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Derivatives in VRTX
reported options exposure · as of Jun 30, 2026CallValue
$496,730
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Vontobel Holding Ltd. holds $98,796,822 across 44 Biotechnology names. VRTX ranks #1 (41.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
81,525 | $40,495,910 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
33,169 | $20,682,197 | |
| 3 | MRNA |
Moderna, Inc.
|
87,541 | $6,130,496 | |
| 4 | BNTX |
BioNTech SE
|
61,238 | $5,698,195 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
153,242 | $4,018,005 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
35,363 | $2,633,836 | |
| 7 | TARS |
Tarsus Pharmaceuticals, Inc.
|
40,000 | $2,517,600 | |
| 8 | SLS |
SELLAS Life Sciences Group, Inc.
|
146,762 | $2,166,207 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $496,730 | 1,000 | Call | Defined | 2026-08-03 | |
| 2026-06-30 | $40,495,910 | 81,525 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $37,232,503 | 83,380 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $47,732,910 | 105,287 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $43,331,831 | 110,642 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $31,964,468 | 71,798 | Shares | Defined | 2025-07-23 | |
| 2025-03-31 | $36,267,443 | 74,806 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $76,089,760 | 188,949 | Shares | Defined | 2025-01-30 | |
| 2024-09-30 | $52,691,700 | 113,296 | Shares | Defined | 2024-10-16 | |
| 2024-06-30 | $74,446,796 | 158,830 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $45,303,922 | 108,380 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $24,996,878 | 61,434 | Shares | Defined | 2024-06-04 | |
| 2023-09-30 | $23,519,045 | 67,634 | Shares | Defined | 2024-06-04 | |
| 2023-06-30 | $23,928,822 | 67,997 | Shares | Defined | 2024-06-04 | |
| 2023-03-31 | $18,151,180 | 57,610 | Shares | Defined | 2024-06-04 | |
| 2022-12-31 | $18,106,215 | 62,699 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,119,340 | 59,126 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $20,510,928 | 72,788 | Shares | Defined | 2022-07-27 | |
| 2022-03-31 | $23,667,628 | 90,691 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,626,661 | 116,697 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $17,729,782 | 97,744 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $15,813,032 | 78,426 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $14,320,268 | 66,640 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $13,723,790 | 58,068 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||